عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

NCR graphs - Incidence rates by year

- All cancer including non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer including non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- All cancer excluding non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer excluding non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Oesophagus cancer, crude incidence rate, males, 2005-2015
- Oesophagus cancer, crude incidence rate, females, 2005-2015

- Stomach cancer, crude incidence rate, males, 2005-2015
- Stomach cancer, crude incidence rate, females, 2005-2015

- Colo-rectal cancer, crude incidence rate, males, 2005-2015
- Colo-rectal cancer, crude incidence rate, females, 2005-2015

- Liver cancer, crude incidence rate, males, 2005-2015
- Liver cancer, crude incidence rate, females, 2005-2015

- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, males, 2005-2015
- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, females, 2005-2015

- Pancreas cancer, crude incidence rate, males, 2005-2015
- Pancreas cancer, crude incidence rate, females, 2005-2015

- Larynx cancer, crude incidence rate, males, 2005-2015
- Larynx cancer, crude incidence rate, females, 2005-2015

- Trachea-bronchus-lung cancer, crude incidence rate, males, 2005-2015
- Trachea-bronchus-lung cancer, crude incidence rate, females, 2005-2015

- Bone cancer, crude incidence rate, males, 2005-2015
- Bone cancer, crude incidence rate, females, 2005-2015

- Melanoma, crude incidence rate, males, 2005-2015
- Melanoma, crude incidence rate, females, 2005-2015

- Non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- Non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Mesothelioma, crude incidence rate, males, 2005-2015
- Mesothelioma, crude incidence rate, females, 2005-2015

- Breast cancer, crude incidence rate, males, 2005-2015
- Breast cancer, crude incidence rate, females, 2005-2015

- Col uteri cancer, crude incidence rate, females, 2005-2015
- Corpus uteri cancer, crude incidence rate, females, 2005-2015
- Ovary cancer, crude incidence rate, females, 2005-2015

- Prostate cancer, crude incidence rate, males, 2005-2015
- Testis cancer, crude incidence rate, males, 2005-2015

- Kidney cancer, crude incidence rate, males, 2005-2015
- Kidney cancer, crude incidence rate, females, 2005-2015

- Bladder cancer, crude incidence rate, males, 2005-2015
- Bladder cancer, crude incidence rate, females, 2005-2015

- Brain and central nervous system cancer, crude incidence rate, males, 2005-2015
- Brain and central nervous system cancer, crude incidence rate, females, 2005-2015

- Thyroid cancer, crude incidence rate, males, 2005-2015
- Thyroid cancer, crude incidence rate, females, 2005-2015

- Hodgkin's lymphoma, crude incidence rate, males, 2005-2015
- Hodgkin's lymphoma, crude incidence rate, females, 2005-2015

- Non-Hodgkin lymphoma, crude incidence rate, males, 2005-2015
- Non-Hodgkin lymphoma, crude incidence rate, females, 2005-2015

- Lymphoma all types, crude incidence rate, males, 2005-2015
- Lymphoma all types, crude incidence rate, females, 2005-2015

- Multiple myeloma, crude incidence rate, males, 2005-2015
- Multiple myeloma, crude incidence rate, females, 2005-2015

- Lymphoid leukemia, crude incidence rate, males, 2005-2015
- Lymphoid leukemia, crude incidence rate, females, 2005-2015

- Myeloid leukemia, crude incidence rate, males, 2005-2015
- Myeloid leukemia, crude incidence rate, females, 2005-2015

- Leukemia all types, crude incidence rate, males, 2005-2015
- Leukemia all types, crude incidence rate, females, 2005-2015

 
    1
    ...
    140
    141
    142
    143
    144
    145
    ...
    179
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
S01AA12 TOBRACIN G Tobramycin - 0.3% 0.3% Ointment 280,863 L.L
S01AA23 NETTACIN B Netilmicin - 0.3% 0.3% Drops solution 681,328 L.L
S01AA23 NETTACIN B Netilmicin - 0.3% 0.3% Ointment 593,978 L.L
S01AE01 OFLOX B Ofloxacin - 3mg/ml 0.3% Drops solution 366,869 L.L
S01AE01 OFLOX B Ofloxacin - 0.3% 0.3% Drops solution 366,869 L.L
A03AB02 GLYCOPYRROLATE B Glycopyronium Bromide - 0.2mg/ml 0.2mg/ml Injectable solution 7,238,185 L.L
C02AC05 CYNT B Moxonidine - 0.2mg 0.2mg Tablet, film coated 901,735 L.L
D10AX03 SKINOREN B Azelaic acid - 0.2g/g 0.2g/g Cream 722,987 L.L
A11CC06 HIDROFEROL G Calcifediol - 0.266mg 0.266mg Capsule, soft 1,316,966 L.L
S01GX08 ZALERG G Ketotifen - 0.25mg/ml 0.25mg/ml Drops solution 446,156 L.L
A03BA01 ATROPINE I.V. 0.25 MG. G Atropine - 0.25mg/ml 0.25mg/ml Injectable solution 2,412,129 L.L
B01AC17 AGGRASTAT B Tirofiban hydrochloride monohydrate - 0.25mg/ml 0.25mg/ml Injectable concentrated solution 18,280,324 L.L
D07AC04 FLUOCINOLONE ACETONIDE G Fluocinolone acetonide - 0.25mg/g 0.25mg/g Cream 296,925 L.L
N02CX01 APIZINE G Pizotifen - 0.25mg/5ml 0.25mg/5ml Syrup 505,541 L.L
A04AA05 ALOXI B Palonosetron HCl - 0.25mg/5ml 0.25mg/5ml Injectable solution 3,656,595 L.L
H01CC01 ORGALUTRAN B Ganirelix - 0.25mg/0.5ml 0.25mg/0.5ml Injectable solution 2,383,977 L.L
H01CC01 ORGALUTRAN B Ganirelix - 0.25mg/0.5ml 0.25mg/0.5ml Injectable solution 2,383,977 L.L
A10BJ06 OZEMPIC B Semaglutide - 0.25mg 0.25mg Injectable solution 10,927,526 L.L
H01CC02 CETROTIDE B Cetrorelix (acetate) - 0.25mg 0.25mg Injectable lyophilised powder for solution+diluent 3,420,079 L.L
H01CC02 CETROTIDE B Cetrorelix (acetate) - 0.25mg 0.25mg Injectable lyophilised powder for solution+diluent 21,354,452 L.L
H01CC02 CETROTIDE B Cetrorelix (acetate) - 0.25mg 0.25mg Injectable lyophilised powder for solution+diluent 21,354,452 L.L
H01CC02 CETROTIDE B Cetrorelix (acetate) - 0.25mg 0.25mg Injectable lyophilised powder for solution+diluent 3,420,079 L.L
L01XK04 TALZENNA B Talazoparib - 0.25mg 0.25mg Capsule 133,836,699 L.L
N05BA12 ALPRAZOLAM BIOGARAN G Alprazolam - 0.25mg 0.25mg Tablet, scored 115,570 L.L
C01AA05 LANOXIN B Digoxin - 0.25mg 0.25mg Tablet 215,015 L.L
L04AA42 MAYZENT B Siponimod - 0.25mg 0.25mg Tablet, film coated 15,102,158 L.L
L04AA42 MAYZENT B Siponimod - 0.25mg 0.25mg Tablet, film coated 124,258,444 L.L
A11CC03 ONE-ALPHA B Alfacalcidol - 0.25mcg 0.25mcg Capsule 1,138,235 L.L
D03AX RENEBO G ?-sitosterol - 0.25% w/w 0.25% w/w Ointment 456,906 L.L
D03AX MEBO B ?-sitosterol - 0.25% 0.25% Ointment 760,615 L.L
    1
    ...
    140
    141
    142
    143
    144
    145
    ...
    179
Sitemap
© Copyrights reserved to Ministry of Public Health 2025